Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

[1]  L. Mccauley,et al.  Calcium Sensing Receptor Function Supports Osteoblast Survival and Acts as a Co‐Factor in PTH Anabolic Actions in Bone , 2016, Journal of cellular biochemistry.

[2]  R. Hinton,et al.  Chondrocytes Directly Transform into Bone Cells in Mandibular Condyle Growth , 2015, Journal of dental research.

[3]  E. Schipani,et al.  HIF-1α and growth plate development: what we really know. , 2015, BoneKEy reports.

[4]  W. Hul,et al.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis , 2015, Nature Reviews Rheumatology.

[5]  I. Reid.  Short-term and long-term effects of osteoporosis therapies , 2015, Nature Reviews Endocrinology.

[6]  L. Cianferotti,et al.  The calcium-sensing receptor in bone metabolism: from bench to bedside and back , 2015, Osteoporosis International.

[7]  L. Fraser,et al.  Type 1 Diabetes and Osteoporosis: From Molecular Pathways to Bone Phenotype , 2015, Journal of osteoporosis.

[8]  G. Hendy,et al.  The calcium-sensing receptor in bone—mechanistic and therapeutic insights , 2015, Nature Reviews Endocrinology.

[9]  D. Hu,et al.  The Multifaceted Role of the Vasculature in Endochondral Fracture Repair , 2015, Front. Endocrinol..

[10]  D. Chan,et al.  Fate of growth plate hypertrophic chondrocytes: Death or lineage extension? , 2015, Development, growth & differentiation.

[11]  John H. White,et al.  Vitamin D and its receptor during late development. , 2015, Biochimica et biophysica acta.

[12]  H. Kronenberg,et al.  Role of G-proteins in the differentiation of epiphyseal chondrocytes. , 2014, Journal of molecular endocrinology.

[13]  Leiting Pan,et al.  Elevation of Extracellular Ca2+ Induces Store-Operated Calcium Entry via Calcium-Sensing Receptors: A Pathway Contributes to the Proliferation of Osteoblasts , 2014, PloS one.

[14]  A. Christopoulos,et al.  Roles of intraloops‐2 and ‐3 and the proximal C‐terminus in signalling pathway selection from the human calcium‐sensing receptor , 2014, FEBS letters.

[15]  Liu Yang,et al.  Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation , 2014, Proceedings of the National Academy of Sciences.

[16]  C. Xian,et al.  Recent research on the growth plate: Mechanisms for growth plate injury repair and potential cell-based therapies for regeneration. , 2014, Journal of molecular endocrinology.

[17]  D. Bikle,et al.  Ephrin B2/EphB4 Mediates the Actions of IGF‐I Signaling in Regulating Endochondral Bone Formation , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  Lin Chen,et al.  Recent research on the growth plate: Advances in fibroblast growth factor signaling in growth plate development and disorders. , 2014, Journal of molecular endocrinology.

[19]  Y. Kunisaki,et al.  Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. , 2014, Developmental cell.

[20]  A. Mobasheri,et al.  Regulation of chondrogenesis by protein kinase C: Emerging new roles in calcium signalling. , 2014, Cellular signalling.

[21]  D. Chan,et al.  The chondrocytic journey in endochondral bone growth and skeletal dysplasia. , 2014, Birth defects research. Part C, Embryo today : reviews.

[22]  Janet L. Crane,et al.  Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling. , 2014, The Journal of clinical investigation.

[23]  Xu Cao,et al.  Function of matrix IGF-1 in coupling bone resorption and formation , 2014, Journal of Molecular Medicine.

[24]  Sara E Strecker,et al.  Osterix-Cre Labeled Progenitor Cells Contribute to the Formation and Maintenance of the Bone Marrow Stroma , 2013, PloS one.

[25]  R. Baron,et al.  Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH* , 2013, The Journal of Biological Chemistry.

[26]  D. Ward,et al.  Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[27]  D. Riccardi,et al.  The extracellular calcium-sensing receptor, CaSR, in fetal development. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[28]  D. Shoback,et al.  Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[29]  A. Christopoulos,et al.  Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells. , 2013, American journal of physiology. Endocrinology and metabolism.

[30]  T. Michigami.  Regulatory mechanisms for the development of growth plate cartilage , 2013, Cellular and Molecular Life Sciences.

[31]  M. Tonelli,et al.  Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials , 2013, PLoS medicine.

[32]  B. Pieske,et al.  Cinacalcet hydrochloride for the treatment of hyperparathyroidism , 2013, Expert opinion on pharmacotherapy.

[33]  I. Salusky,et al.  Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease–mineral bone disorders (CKD-MBD) in children , 2013, Pediatric Nephrology.

[34]  R. Josse,et al.  Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis , 2013, Current medical research and opinion.

[35]  L. Qin,et al.  Amphiregulin-EGFR Signaling Mediates the Migration of Bone Marrow Mesenchymal Progenitors toward PTH-Stimulated Osteoblasts and Osteocytes , 2012, PloS one.

[36]  L. Calvi,et al.  PTH expands short-term murine hemopoietic stem cells through T cells. , 2012, Blood.

[37]  M. Hurley,et al.  Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation , 2012, Journal of cellular physiology.

[38]  J. Bilezikian,et al.  Combination anabolic and antiresorptive therapy for osteoporosis. , 2012, Endocrinology and metabolism clinics of North America.

[39]  S. Conway,et al.  Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin , 2012, Proceedings of the National Academy of Sciences.

[40]  D. Riche,et al.  Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis , 2012, The Annals of pharmacotherapy.

[41]  J. Connell,et al.  Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. , 2012, Human molecular genetics.

[42]  E. Greenfield.  Anabolic effects of intermittent PTH on osteoblasts. , 2012, Current molecular pharmacology.

[43]  D. Bikle,et al.  Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone. , 2012, Current molecular pharmacology.

[44]  A. Robling,et al.  Immortalization and characterization of osteoblast cell lines generated from wild‐type and Nmp4‐null mouse bone marrow stromal cells using murine telomerase reverse transcriptase (mTERT) , 2012, Journal of cellular physiology.

[45]  S. Takeda,et al.  Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor , 2012, Proceedings of the National Academy of Sciences.

[46]  P. Sexton,et al.  Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. , 2012, Endocrinology.

[47]  K. Matsuo,et al.  Bone cell interactions through Eph/ephrin , 2012, Cell adhesion & migration.

[48]  P. Kostenuik,et al.  Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. , 2012, Clinical therapeutics.

[49]  D. Riccardi,et al.  The calcium-sensing receptor beyond extracellular calcium homeostasis: conception, development, adult physiology, and disease. , 2012, Annual review of physiology.

[50]  G. Johnson.  Denosumab (prolia) for treatment of postmenopausal osteoporosis. , 2012, American family physician.

[51]  Alex R. B. Thomsen,et al.  Biased agonism of the calcium-sensing receptor. , 2012, Cell calcium.

[52]  N. Jørgensen,et al.  Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans , 2012, Scandinavian journal of clinical and laboratory investigation.

[53]  J. Bilezikian,et al.  Denosumab for the Treatment of Osteoporosis and Cancer‐Related Conditions , 2012, Clinical pharmacology and therapeutics.

[54]  D. Shoback,et al.  Osteoblast extracellular Ca2+‐sensing receptor regulates bone development, mineralization, and turnover , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  Liping Xiao,et al.  The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression. , 2011, Biochemical and biophysical research communications.

[56]  T. Clemens,et al.  IGF‐1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  R. Mason,et al.  An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts* , 2011, The Journal of Biological Chemistry.

[58]  G. Passeri,et al.  PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  E. Brown,et al.  Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR). , 2010, Biochemical pharmacology.

[60]  E. Canalis.  Update in new anabolic therapies for osteoporosis. , 2010, The Journal of clinical endocrinology and metabolism.

[61]  O. Leupin,et al.  Does osteocytic SOST suppression mediate PTH bone anabolism? , 2010, Trends in Endocrinology & Metabolism.

[62]  J. Lincoln,et al.  Reduced Sox9 Function Promotes Heart Valve Calcification Phenotypes In Vivo , 2010, Circulation research.

[63]  P. Marie.  The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. , 2010, Bone.

[64]  A. Abou-Samra,et al.  Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. , 2010, Cellular signalling.

[65]  Xia Li,et al.  The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis , 2010, Molecular Biology Reports.

[66]  Hui Shen,et al.  Impaired Osteoblast Function in GPRC6A Null Mice , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  V. Sreenivas,et al.  Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism , 2009, Clinical endocrinology.

[68]  M. Rybchyn,et al.  Osteoblasts play key roles in the mechanisms of action of strontium ranelate , 2009, British journal of pharmacology.

[69]  O. Fromigué,et al.  Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelate , 2009 .

[70]  Minnkyong Lee,et al.  Parathyroid hormone signaling in bone and kidney , 2009, Current opinion in nephrology and hypertension.

[71]  A. C. Thé,et al.  Prevalence of cortical osteoporosis in mild and severe primary hyperparathyroidism and its relationship with bone markers and vitamin D status. , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[72]  Glenville Jones,et al.  Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction , 2008, Clinical endocrinology.

[73]  D. Shoback,et al.  The Extracellular Calcium-Sensing Receptor (CaSR) Is a Critical Modulator of Skeletal Development , 2008, Science Signaling.

[74]  J. Lian,et al.  New Insights in Bone Biology: Unmasking Skeletal Effects of the Extracellular Calcium–Sensing Receptor , 2008, Science Signaling.

[75]  M. Bouxsein,et al.  Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.

[76]  L. Raisz,et al.  Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro. , 2008, Biochemical and biophysical research communications.

[77]  D. Shoback.  Clinical practice. Hypoparathyroidism. , 2008, The New England journal of medicine.

[78]  D. Bikle.  Growth Hormone/Insulin‐Like Growth Factor‐1/PTH Axis in Bone , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  J. Hoenderop,et al.  Calcium and phosphate homeostasis: Concerted interplay of new regulators , 2008, Annals of medicine.

[80]  N. Partridge,et al.  Parathyroid Hormone Stimulation of Noncanonical Wnt Signaling in Bone , 2007, Annals of the New York Academy of Sciences.

[81]  D. Shoback,et al.  Type B γ-Aminobutyric Acid Receptors Modulate the Function of the Extracellular Ca2+-Sensing Receptor and Cell Differentiation in Murine Growth Plate Chondrocytes , 2007 .

[82]  L. Jan,et al.  Complex Formation with the Type B γ-Aminobutyric Acid Receptor Affects the Expression and Signal Transduction of the Extracellular Calcium-sensing Receptor , 2007, Journal of Biological Chemistry.

[83]  D. Shoback,et al.  Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone. , 2007, Endocrinology.

[84]  R. Jilka.  Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. , 2007, Bone.

[85]  D. Nurminsky,et al.  Regulation of chondrocyte differentiation by actin-severing protein adseverin. , 2007, Developmental biology.

[86]  Zining Wu,et al.  Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. , 2006, Bone.

[87]  E. Brown,et al.  The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  D. Shoback,et al.  WITHDRAWN: Type B gamma-aminobutyric Acid Receptors Modulate the Expression and Function of the Extracellular Ca2+-sensing Receptor in Murine Growth Plate Chondrocytes. , 2006, Endocrinology.

[89]  Eiichiro Nakamura,et al.  Kinetics of tamoxifen‐regulated Cre activity in mice using a cartilage‐specific CreERT to assay temporal activity windows along the proximodistal limb skeleton , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[90]  M. Holick.  Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[91]  M. Bouxsein,et al.  The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. , 2006, The Journal of endocrinology.

[92]  C. Malemud.  Matrix metalloproteinases: role in skeletal development and growth plate disorders. , 2006, Frontiers in bioscience : a journal and virtual library.

[93]  H. Kronenberg.  PTHrP and Skeletal Development , 2006, Annals of the New York Academy of Sciences.

[94]  D. Shoback,et al.  Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. , 2005, Endocrinology.

[95]  M. Karperien,et al.  Multiple Mechanisms Are Involved in Inhibition of Osteoblast Differentiation by PTHrP and PTH in KS483 Cells , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[96]  Wenhan Chang,et al.  Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. , 2005, Endocrinology.

[97]  L. Quarles,et al.  Osteoblast calcium‐sensing receptor has characteristics of ANF/7TM receptors , 2005, Journal of cellular biochemistry.

[98]  L. Gelbert,et al.  Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray , 2005, Journal of cellular biochemistry.

[99]  Sungkil Lim,et al.  Identification of parathyroid hormone-regulated proteins in mouse bone marrow cells by proteomics. , 2005, Biochemical and biophysical research communications.

[100]  Tatsuya Kobayashi,et al.  Minireview: transcriptional regulation in development of bone. , 2005, Endocrinology.

[101]  J. Monchik,et al.  Normocalcemic hyperparathyroidism in patients with osteoporosis. , 2004, Surgery.

[102]  J. Pettifor.  Nutritional rickets: deficiency of vitamin D, calcium, or both? , 2004, The American journal of clinical nutrition.

[103]  L. Weinstein,et al.  Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[104]  E. Brown,et al.  pH Sensing by the Calcium-sensing Receptor* , 2004, Journal of Biological Chemistry.

[105]  H. Woitge,et al.  Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. , 2004, The International journal of developmental biology.

[106]  S. Bandyopadhyay,et al.  Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. , 2004, Endocrinology.

[107]  Katherine E Yutzey,et al.  Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[108]  A. Hjelmeland,et al.  Selective Deficiency of the “Bone-related” Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis* , 2004, Journal of Biological Chemistry.

[109]  D. Miao,et al.  Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[110]  L. Quarles,et al.  A Novel Cation‐Sensing Mechanism in Osteoblasts Is a Molecular Target for Strontium , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[111]  D. Ward,et al.  Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[112]  L. Komuves,et al.  The role of the calcium-sensing receptor in epidermal differentiation. , 2004, Cell calcium.

[113]  L. Qin,et al.  Parathyroid hormone: a double-edged sword for bone metabolism , 2004, Trends in Endocrinology & Metabolism.

[114]  D. Shoback,et al.  Extracellular Ca2+-sensing receptors--an overview. , 2004, Cell calcium.

[115]  Mei Bai,et al.  Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.

[116]  M. Delivoria-Papadopoulos,et al.  Effects of Ca2‐sensing receptor activation in the growth plate , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[117]  J. Wit,et al.  Systemic and local regulation of the growth plate. , 2003, Endocrine reviews.

[118]  A. Kivitz,et al.  Management of Postmenopausal Osteoporosis , 2003, The Journal of the American Osteopathic Association.

[119]  R. L. Cain,et al.  Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. , 2003, Bone.

[120]  L. Prézeau,et al.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[121]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[122]  M. Hediger,et al.  The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. , 2003, The Journal of clinical investigation.

[123]  D. Biskobing.  Novel therapies for osteoporosis , 2003, Expert opinion on investigational drugs.

[124]  G. Karsenty,et al.  Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. , 2003, The Journal of clinical investigation.

[125]  F. Collins,et al.  Hyperparathyroidism in hereditary syndromes: special expressions and special managements. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[126]  Raoul Rooman,et al.  IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. , 2002, The Journal of endocrinology.

[127]  H. Kronenberg,et al.  The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. , 2002, Developmental cell.

[128]  D. Miao,et al.  Parathyroid hormone is essential for normal fetal bone formation. , 2002, The Journal of clinical investigation.

[129]  H. V. Van Wart,et al.  Proteolysis Involving Matrix Metalloproteinase 13 (Collagenase‐3) Is Required for Chondrocyte Differentiation That Is Associated with Matrix Mineralization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[130]  S. Soltoff,et al.  Calcium-sensing receptor-mediated activation of phospholipase C-gamma1 is downstream of phospholipase C-beta and protein kinase C in MC3T3-E1 osteoblasts. , 2002, Bone.

[131]  D. Shoback,et al.  Extracellular Ca2+-Sensing Receptors Modulate Matrix Production and Mineralization in Chondrogenic RCJ3.1C5.18 Cells. , 2002, Endocrinology.

[132]  S. Wilt,et al.  Heterodimerization of Calcium Sensing Receptors with Metabotropic Glutamate Receptors in Neurons* , 2001, The Journal of Biological Chemistry.

[133]  S. C. Garner,et al.  Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. , 2001, Endocrinology.

[134]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[135]  K. Hruska,et al.  Receptor-operated osteoclast calcium sensing. , 2001, Endocrinology.

[136]  T. Kawamoto,et al.  Direct inhibition of Indian hedgehog expression by parathyroid hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid in growth plate chondrocyte cultures. , 2001, Experimental cell research.

[137]  M. Montminy,et al.  The CREB family of activators is required for endochondral bone development. , 2001, Development.

[138]  H. Kronenberg,et al.  The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[139]  A. C. Durán,et al.  Formation of cartilage in cardiac semilunar valves of chick and quail. , 2000, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[140]  C. Farquharson,et al.  Chondrocytes and longitudinal bone growth: the development of tibial dyschondroplasia. , 2000, Poultry science.

[141]  E. Brown,et al.  Extracellular calcium-sensing-receptor (CaR)-mediated opening of an outward K(+) channel in murine MC3T3-E1 osteoblastic cells: evidence for expression of a functional CaR. , 2000, Bone.

[142]  B. R. Smith,et al.  Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. , 2000, The Journal of clinical investigation.

[143]  V. Lefebvre,et al.  Phosphorylation of SOX9 by Cyclic AMP-Dependent Protein Kinase A Enhances SOX9's Ability To Transactivate aCol2a1 Chondrocyte-Specific Enhancer , 2000, Molecular and Cellular Biology.

[144]  D. Ovchinnikov,et al.  Col2a1‐directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice , 2000, Genesis.

[145]  A. McMahon,et al.  Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. , 2000, Development.

[146]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[147]  R. Baron,et al.  Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. , 1999, The Journal of clinical investigation.

[148]  B. Hollis,et al.  Rickets in Nigerian children: response to calcium supplementation. , 1999, Journal of tropical pediatrics.

[149]  R. Cancedda,et al.  Parathyroid Hormone [PTH(1–34)] and Parathyroid Hormone–Related Protein [PTHrP(1–34)] Promote Reversion of Hypertrophic Chondrocytes to a Prehypertrophic Proliferating Phenotype and Prevent Terminal Differentiation of Osteoblast‐like Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[150]  K. Chihara,et al.  High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. , 1999, Biochemical and biophysical research communications.

[151]  T. Rosol,et al.  3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. , 1999, Endocrinology.

[152]  L. Komuves,et al.  Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. , 1999, Endocrinology.

[153]  W. H. Bergstrom.  When you see rickets, consider calcium deficiency. , 1998, The Journal of pediatrics.

[154]  B. Lanske,et al.  The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[155]  D. Bikle,et al.  The Calcium Sensing Receptor and Its Alternatively Spliced Form in Keratinocyte Differentiation* , 1998, The Journal of Biological Chemistry.

[156]  E. Brown,et al.  The Calcium-sensing Receptor Is Localized in Caveolin-rich Plasma Membrane Domains of Bovine Parathyroid Cells* , 1998, The Journal of Biological Chemistry.

[157]  G. Mazzuoli,et al.  Primary hyperparathyroidism and osteoporosis , 1998, Aging.

[158]  T. Kameda,et al.  Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. , 1998, Biochemical and biophysical research communications.

[159]  D. Shoback,et al.  Coupling of Calcium Receptors to Inositol Phosphate and Cyclic AMP Generation in Mammalian Cells and Xenopus laevis Oocytes and Immunodetection of Receptor Protein by Region‐Specific Antipeptide Antisera , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[160]  J. Glowacki,et al.  Expression of an Extracellular Calcium‐Sensing Receptor in Human and Mouse Bone Marrow Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[161]  J. Helms,et al.  Expression of indian hedgehog, bone morphogenetic protein 6 and gli during skeletal morphogenesis 1 This work was presented in part at the 43rd Annual Meeting of the Orthopaedic Research Society, San Francisco, CA, February 1997. 1 , 1997, Mechanisms of Development.

[162]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[163]  A. Yamaguchi,et al.  Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. , 1997, The Journal of clinical investigation.

[164]  J. Puzas,et al.  Differential regulation of type‐II and type‐X collagen synthesis by parathyroid hormone‐related protein in chick growth‐plate chondrocytes , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[165]  B. Lanske,et al.  PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth , 1996, Science.

[166]  L. Gerstenfeld,et al.  Expression of bone‐specific genes by hypertrophic chondrocytes: Implications of the complex functions of the hypertrophic chondrocyte during endochondral bone development , 1996, Journal of cellular biochemistry.

[167]  E. Brown,et al.  Three inherited disorders of calcium sensing. , 1996, Medicine.

[168]  J. Seidman,et al.  A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1995, Nature Genetics.

[169]  M. Pines,et al.  Synthesis and phosphorylation of osteopontin by avian epiphyseal growth-plate chondrocytes as affected by differentiation. , 1995, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[170]  R. Swiderski,et al.  Type II collagen is transiently expressed during avian cardiac valve morphogenesis , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[171]  B. Genge,et al.  Modulation of cultured chicken growth plate chondrocytes by transforming growth factor‐β1 and basic fibroblast growth factor , 1992, Journal of cellular biochemistry.

[172]  M. Freeman,et al.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[173]  C. Huang,et al.  Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: Further evidence for a “calcium receptor” , 1991, Journal of cellular physiology.

[174]  D. Bonen,et al.  Elevated extracellular calcium concentrations induce type X collagen synthesis in chondrocyte cultures , 1991, The Journal of cell biology.

[175]  H. Datta,et al.  The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts , 1989, Bioscience reports.

[176]  J. Meldolesi,et al.  Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. , 1989, The Journal of biological chemistry.

[177]  I A Silver,et al.  Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. , 1988, Experimental cell research.

[178]  L. Mathews,et al.  Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. , 1988, Endocrinology.

[179]  S. U. Toverud,et al.  Effects of high dietary contents of calcium and phosphorus on mineral metabolism and growth of vitamin D-deficient suckling and weaned rats. , 1987, Bone and mineral.

[180]  E. Brown,et al.  High extracellular Ca2+ and Mg2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells , 1987, FEBS letters.

[181]  A. Dahlström,et al.  Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate. , 1986, Science.

[182]  E. Brown,et al.  Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells. , 1983, Endocrinology.

[183]  K. Yang,et al.  A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia , 2014, Osteoporosis International.

[184]  T. Michigami.  Current understanding on the molecular basis of chondrogenesis. , 2014, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[185]  T. Ozgurtas,et al.  The role of visfatin in the pathogenesis of gestational diabetes mellitus , 2011 .

[186]  D. Shoback,et al.  Assessing constitutive activity of extracellular calcium-sensing receptors in vitro and in bone. , 2010, Methods in enzymology.

[187]  M. Peacock.  Calcium metabolism in health and disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[188]  O. Fromigué,et al.  Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate. , 2009, Journal of cellular and molecular medicine.

[189]  S. Libutti,et al.  Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor. , 2007, Molecular endocrinology.

[190]  R. Baron,et al.  Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation , 2005 .

[191]  S. Yano,et al.  The calcium-sensing receptor. , 2005 .

[192]  K. Hujer,et al.  The Ca2+-sensing receptor couples to Galpha12/13 to activate phospholipase D in Madin-Darby canine kidney cells. , 2004, American journal of physiology. Cell physiology.

[193]  N. Amizuka,et al.  Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development. , 2004, Bone.

[194]  T. Shimo,et al.  Syndecan-3: a cell-surface heparan sulfate proteoglycan important for chondrocyte proliferation and function during limb skeletogenesis , 2004, Journal of Bone and Mineral Metabolism.

[195]  D. Lacey,et al.  In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells. , 2003, Critical reviews in eukaryotic gene expression.

[196]  K. von der Mark,et al.  Role of c‐fos in the regulation of type X collagen gene expression by PTH and PTHrP: Localization of a PTH/PTHrP‐responsive region in the human COL10A1 enhancer , 2002, Journal of cellular biochemistry.

[197]  D. Shoback,et al.  Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. , 2002, Endocrinology.

[198]  R. L. Cain,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation , 2022 .

[199]  L. Komuves,et al.  Expression and signal transduction of calcium-sensing receptors in cartilage and bone. , 1999, Endocrinology.

[200]  M. Amling,et al.  Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. , 1998, Endocrinology.

[201]  D. Hill,et al.  Peptide growth factors and their interactions during chondrogenesis. , 1992, Progress in growth factor research.

[202]  E. Brown,et al.  Divalent cations suppress 3',5'-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells. , 1989, Endocrinology.

[203]  S. Ma,et al.  Induction and maintenance of new bone formation by growth and differentiation factors. , 1988, Annales chirurgiae et gynaecologiae.

[204]  R. Baron,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Rescue of the Skeletal Phenotype of Vitamin D Receptor- Ablated Mice in the Setting of Normal Mineral Ion , 2022 .